DNMT3A R882 mutations promote anthracycline resistance in acute myeloid leukemia through impaired nucleosome remodeling

Although the majority of acute myeloid leukemia (AML) patients initially respond to chemotherapy, many patients subsequently relapse; the mechanistic basis for AML persistence following chemotherapy has not been delineated. Recurrent somatic mutations in DNA methyltransferase 3A (DNMT3A), most frequ...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Nat Med
Huvudupphovsmän: Guryanova, Olga A., Shank, Kaitlyn, Spitzer, Barbara, Luciani, Luisa, Koche, Richard P., Garrett-Bakelman, Francine E., Ganzel, Chezi, Durham, Benjamin H., Mohanty, Abhinita, Hoermann, Gregor, Rivera, Sharon A., Chramiec, Alan G., Pronier, Elodie, Bastian, Lennart, Keller, Matthew D., Tovbin, Daniel, Loizou, Evangelia, Weinstein, Abby R., Gonzalez, Adriana Rodriguez, Lieu, Yen, Rowe, Jacob M., Pastore, Friederike, McKenney, Anna Sophia, Krivtsov, Andrei V., Sperr, Wolfgang R., Cross, Justin R., Mason, Christopher E., Tallman, Martin S., Arcila, Maria E., Abdel-Wahab, Omar, Armstrong, Scott A., Kubicek, Stefan, Staber, Philipp B., Gönen, Mithat, Paietta, Elisabeth M., Melnick, Ari M., Nimer, Stephen D., Mukherjee, Siddhartha, Levine, Ross L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5359771/
https://ncbi.nlm.nih.gov/pubmed/27841873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4210
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk